Skip to main content
. 2022 Jan 11;42(2):130–135. doi: 10.1097/INF.0000000000003779

FIGURE 2.

FIGURE 2.

Comparison of serum or plasma antigen concentrations in COVID-19 patients grouped by severity, clinical features and symptoms. (A) Nucleocapsid measurements for all included COVID-19 patients. (B) Nucleocapsid measurements for COVID-19 patients were sampled within the first 3 days of hospitalization. (C) Spike measurements for all included COVID-19 patients. (D) Spike measurements for COVID-19 patients were sampled within the first 3 days of hospitalization. Boxplots denote median (central mark), interquartile range (IQR; top and bottom of box), and range (whiskers) excluding outliers (defined as points which exceed the 75th percentile by more than 1.5 times IQR). P values >0.05 except where indicated.